Novartis CEO says U.S. plant gets clearance by FDA inspectors

ZURICH Fri Nov 9, 2012 10:35pm IST

A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011. REUTERS/Arnd Wiegmann

A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011.

Credit: Reuters/Arnd Wiegmann

Related Topics

Stocks

   

ZURICH (Reuters) - Swiss drugmaker Novartis's plant in Colorado, has just passed an inspection by U.S. regulators, giving it hope that quality control problems in its North American plants are being solved.

Last December, the U.S. Food and Drug Administration cited Novartis for significant violations of manufacturing regulations at its three generic drug plants in Colorado, North Carolina and Quebec, Canada.

Chief Executive Joseph Jimenez told the Finanz und Wirtschaft newspaper in an interview on Friday that Novartis had been working since January to bring quality standards back up to the level of other Novartis plants.

"In Bloomfield, Colorado, the FDA confirmed to us just today after an inspection that the plant is in such a condition. This development makes me confident. We are on the right track but must not stop," he said.

Novartis's consumer health division has also suffered from manufacturing problems at its Lincoln site, which has annualised sales of $1 billion. Novartis said last month it was taking longer than expected to restart commercial production.

Jimenez has rejected suggestions that a manufacturing glitch that led to Italy banning Novartis flu vaccines last month was the latest in a series of quality control problems.

Italian health authorities lifted the ban on Friday after accepting that the drugmaker had showed they posed no risk to safety. Canadian and Swiss health authorities had already lifted similar bans.

(Reporting by Emma Thomasson; Editing by Greg Mahlich)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Encephalitis in India

REUTERS SHOWCASE

No Relief

No Relief

Paracetamol no better than placebo for low back pain, study finds.  Full Article 

Fighting AIDS

Fighting AIDS

Bill Clinton says AIDS-free generation 'within reach'.  Full Article 

Obamacare Enrollment

Obamacare Enrollment

Over 10 million U.S. adults gain coverage under Obamacare: study.  Full Article 

Quality Issue

Quality Issue

Ipca halts U.S. shipments from Ratlam plant after FDA finds violations.  Full Article 

Financial Cost

Financial Cost

Abuse of U.S. generic-drug rules costs billions: report.  Full Article 

Fitness Hooping

Fitness Hooping

Hoopsters put circus-inspired spin on cardio workout.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage